Try GOLD - Free

There's crushing news for people who want to live long

Mint New Delhi

|

April 21, 2025

A wonder drug that a wealthy longevity seeker was testing on himself may have turned out to be a dud

- MANU JOSEPH

A few days ago, Bryan Johnson, a centi-millionaire who has spent millions on reversing ageing—especially his own—posted some bad news for humanity on his YouTube channel. Rapamycin, which for a long time has been the most promising molecule in our quest to prolong youth, was not making him younger; instead, it was "accelerating" his ageing.

Johnson, who is 47 and looks 46, conducts various experiments on himself in his effort to live like a young man for a very long time. I am counting on him. His food consumption is so calibrated that he knows the number of calories he has gulped. He does not eat after 11 am, unless he has to meet people socially and must eat at ungodly hours like 7 pm just to shut them up. He sleeps around 8:30 pm, alone. I know he has high standards for himself because he recently visited Delhi, probably out of ignorance, and refused to breathe the air for too long. Among the most important things he was performing on himself was taking small quantities of rapamycin, a drug that is chiefly used to prevent the body's rejection of organ transplants. It does not have approval as an anti-ageing drug, though it is widely believed to have potential for that. The compound had extended the lifespan of mice and worms beyond ambiguity, and of other animals, too. Johnson was its most famous human test subject.

MORE STORIES FROM Mint New Delhi

Mint New Delhi

Mint New Delhi

PM backs Make in India for chips, mobiles, electronics

Prime Minister Narendra Modi on Wednesday renewed his pitch for Make in India across sectors, from mobiles to semiconductors and electronics, saying the government is accelerating the pace of reforms, offering the best investment opportunities.

time to read

2 mins

October 09, 2025

Mint New Delhi

Road builders sweat as highway tenders dry up

After a prolonged slowdown in orders, India's road construction giants are keeping their fingers crossed for a long-awaited revival.

time to read

2 mins

October 09, 2025

Mint New Delhi

Mint New Delhi

Advertisers push for transparency standards in ad sales

Some of the advertising industry's largest players have joined forces to propose new standards for transparency in the digital auctions that increasingly dominate ad sales.

time to read

4 mins

October 09, 2025

Mint New Delhi

Mint New Delhi

Can Canara Robeco AMC retain equity edge?

Canara Robeco Asset Management Co. (CRAMC), India's second-oldest asset manager, is set to test investor appetite with its ₹1,326-crore initial public offering (IPO), banking on its strong equity focus, rapid growth momentum, and the trusted legacy of its joint promoters-state-run Canara Bank and Netherlands-based Orix Corp. Europe.

time to read

2 mins

October 09, 2025

Mint New Delhi

Mint New Delhi

Will Q2 results put TCS out of its misery?

In business, a quarter can feel like a lifetime. Ask Tata Consultancy Services Ltd's (TCS's) chief executive officer, K. Krithivasan. The July-September period tested the country's largest IT (information technology) services firm on several fronts-one external, and two self-made challenges.

time to read

3 mins

October 09, 2025

Mint New Delhi

Mint New Delhi

India pulls several anti-dumping levies on China, others

New Delhi has quietly allowed the expiry of anti-dumping duties on a range of goods from several countries including China, signalling a recalibration in its approach to trade protection.

time to read

2 mins

October 09, 2025

Mint New Delhi

JSW tweaks auto top deck before EV, truck launch

Sajjan Jindal-led JSW Group has introduced a series of changes to the boards of at least two ofits auto companies and changed the holding company of its component business between August and September, as the conglomerate gears up to launch cars and trucks next financial year.

time to read

2 mins

October 09, 2025

Mint New Delhi

Pharma deals soaring, but top drugmakers hold back

Dealmaking in India’s pharma sector has surged over the past two years as companies seek to beef up their portfolios and reduce reliance on the US market.

time to read

2 mins

October 09, 2025

Mint New Delhi

Has TaMo priced in worst of JLR?

Tata Motors Ltd is gearing up for its long-awaited demerger.

time to read

2 mins

October 09, 2025

Mint New Delhi

Adani taps SBI, Temasek, others for NMIA terminal

Airport entity in talks to raise ₹30,000 crore for Terminal-2 opening in 2029

time to read

3 mins

October 09, 2025

Listen

Translate

Share

-
+

Change font size